Doximity (DOCS) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Doximity · Health Care · ref. ETF XLV · 59 calls · price $25.59
What the company does: Doximity, Inc. operates a digital platform for medical professionals in the United States.
📈 Doximity (DOCS) stock price
$25.59-62.6% over range
Aug 28, 25low $18.01 · high $75.12Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
35% recommend buying · 20 analysts
📊 JPI status : Doximity has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 DOCS price target & analyst consensus — price $25.59
The price target · all analysts combined (19 targets)
Highest target · 1 firm of 19$47+83.7%
Median target · of 19 targets$26.5+3.6%
Lowest target · 2 firms of 19$18-29.7%
Current price$25.59
Where these 19 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1158%
$26 ↔ $47
Below
842%
$18 ↔ $25
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: B of A Securities — 74% of its targets hit on this sector (105 calls tested). It aims for $20 (-22 %), call made on June 30, 2026, maturing on June 30, 2027 (59 d ago).
The 3 reliable analysts
$20-22 %
The 16 other firms
$28.50+11 %
How to read it: the 3 reliable firms are not filtered by optimism — 0 aim above the price, 3 below, hence their $20 median. “The 16 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 20 ratings (last 6 months)
Strong Buy00%
Buy735%
Hold1155%
Sell210%
Strong Sell00%
Go deeper on the analysts
🎯 DOCS price target all
All 59 calls, one by one, with our verdict on each firm.
→ See all 59 targets, analyst by analyst💡 The best analysts on DOCS most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in DOCS? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Doximity? The JPI assistant answers using our backtest data.
📈 Doximity fundamentals: valuation, margins & growth › open the full page
P/E 29.4Net margin 25.5 %Revenue growth +7.3 %Average P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2023
marg. 27 %
2024
Rev +13%Profit +31%
2025
Rev +20%Profit +51%
2026
Rev +13%Profit −12%
🔎 Detailed analyses
✅ Historical analyst reliability on DOCS
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Barclays ↗ | 50% | +21.5% | 2 |
| Jefferies ↗ | 50% | -18.8% | 2 |
| JP Morgan ↗ | 50% | -26.0% | 4 |
| Baird ↗ | 40% | -18.7% | 5 |
| SVB Leerink | 33% | -26.1% | 3 |
| Canaccord Genuity ↗ | 29% | +8.4% | 7 |
| Morgan Stanley ↗ | 29% | -56.1% | 7 |
| Raymond James ↗ | 20% | -36.6% | 10 |
| Needham ↗ | 18% | -25.0% | 11 |
| Berenberg ↗ | 0% | -15.7% | 2 |
See the other 5 firms
| Wells Fargo ↗ | 0% | -45.0% | 4 |
| Keybanc ↗ | 0% | -36.1% | 4 |
| Piper Sandler ↗ | 0% | -22.9% | 4 |
| Goldman Sachs ↗ | 0% | -20.7% | 3 |
| Guggenheim ↗ | 0% | -18.0% | 2 |
📊 What $1,000 invested in Doximity would be worth › open the full page
In short — $1,000 invested in Doximity 10 years ago would be worth $370 today, i.e. -18%/yr on average. Best year: 2024 (+97%), worst: 2022 (-33%). Price performance, excluding dividends.
If I'd invested $1,000 in Doximity
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $376 | -62% |
| 3 years ago | $618 | -38% |
| 5 years ago | $370 | -63% |
Return by year (Doximity)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -52% | $479 (-52%) |
| 2025 | -22% | $376 (-62%) |
| 2024 | +97% | $740 (-26%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Doximity
Loading news…
📋 All analyst calls on DOCS
Filtered on — · ✕ show all
■ Equal-Weight neutral · not a buy · 🎯$27
Price at call : $25.3 — gap to target +7%
Today : $25.59 — gap to target +6%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Aug 21, 27
matures : Aug 21, 27
Truist Securities ↗
Aug 13, 26
■ Hold neutral · not a buy · 🎯$24
Price at call : $24.8 — gap to target -3%
Today : $25.59 — gap to target -6%
🎯 on DOCS : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Aug 13, 27
matures : Aug 13, 27
Wells Fargo ↗
Aug 10, 26
▼ Underweight · 🎯$18
Price at call : $25.63 — upside -30%
Today : $25.59 — upside -30%
🎯 on DOCS : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
■ Neutral neutral · not a buy · 🎯$31
Price at call : $25.63 — gap to target +21%
Today : $25.59 — gap to target +21%
🎯 on DOCS : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Piper Sandler ↗
Aug 7, 26
▲ Overweight · 🎯$47
Price at call : $25.63 — upside +83%
Today : $25.59 — upside +84%
🎯 on DOCS : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Evercore ISI Group ↗
Aug 7, 26
■ In-Line neutral · not a buy · 🎯$40
Price at call : $27.4 — gap to target +46%
Today : $25.59 — gap to target +56%
🎯 on DOCS : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
B of A Securities ↗
Jun 29, 26
▼ Underperform · 🎯$20
Price at call : $20.59 — upside -3%
Today : $25.59 — upside -22%
🎯 on DOCS : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
Goldman Sachs ↗
May 15, 26
■ Neutral neutral · not a buy · 🎯$24
Price at call : $19.58 — gap to target +23%
Today : $25.59 — gap to target -6%
🎯 on DOCS : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : May 15, 27
matures : May 15, 27
See the other 51 calls, newest to oldest
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $18.97 — gap to target +5%
Today : $25.59 — gap to target -22%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : May 15, 27
matures : May 15, 27
Leerink Partners ↗
May 14, 26
▲ Outperform · 🎯$25
Price at call : $18.97 — upside +32%
Today : $25.59 — upside -2%
🎯 on DOCS : 0% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Hold neutral · not a buy · 🎯$19
Price at call : $18.97 — gap to target +0%
Today : $25.59 — gap to target -26%
🎯 on DOCS : no call matured yet · 📊 on Health : 49.1% · +10.3% (112 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Canaccord Genuity ↗
May 14, 26
▲ Buy · 🎯$30
Price at call : $18.97 — upside +58%
Today : $25.59 — upside +17%
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Neutral neutral · not a buy · 🎯$28
Price at call : $18.97 — gap to target +48%
Today : $25.59 — gap to target +9%
🎯 on DOCS : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Goldman Sachs ↗
May 14, 26
■ Neutral neutral · not a buy · 🎯$24
Price at call : $18.97 — gap to target +27%
Today : $25.59 — gap to target -6%
🎯 on DOCS : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Truist Securities ↗
May 14, 26
■ Hold neutral · not a buy · 🎯$19
Price at call : $18.97 — gap to target +0%
Today : $25.59 — gap to target -26%
🎯 on DOCS : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Wells Fargo ↗
May 14, 26
■ Equal-Weight neutral · not a buy · 🎯$18
Price at call : $18.01 — gap to target -0%
Today : $25.59 — gap to target -30%
🎯 on DOCS : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
BMO Capital ↗
May 14, 26
■ Market Perform neutral · not a buy · 🎯$20
Price at call : $18.01 — gap to target +11%
Today : $25.59 — gap to target -22%
🎯 on DOCS : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Neutral neutral · not a buy · 🎯$26
Price at call : $18.01 — gap to target +44%
Today : $25.59 — gap to target +2%
🎯 on DOCS : no call matured yet · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Morgan Stanley ↗
May 14, 26
▲ Overweight · 🎯$35
Price at call : $18.01 — upside +94%
Today : $25.59 — upside +37%
🎯 on DOCS : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Neutral neutral · not a buy
🎯 on DOCS : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Sector Weight neutral · not a buy
🎯 on DOCS : no call matured yet · 📊 on Health : 32.6% · -10.5% (43 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
▲ Buy · 🎯$27
Price at call : $18.01 — upside +50%
Today : $25.59 — upside +6%
🎯 on DOCS : no call matured yet · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Neutral neutral · not a buy · 🎯$18
Price at call : $18.01 — gap to target -0%
Today : $25.59 — gap to target -30%
🎯 on DOCS : no call matured yet · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Wells Fargo ↗
May 11, 26
▲ Overweight · 🎯$32
Price at call : $26.26 — upside +22%
Today : $25.59 — upside +25%
🎯 on DOCS : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
Truist Securities ↗
Apr 20, 26
■ Hold neutral · not a buy · 🎯$29
Price at call : $24.39 — gap to target +19%
Today : $25.59 — gap to target +13%
🎯 on DOCS : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Apr 20, 27
matures : Apr 20, 27
B of A Securities ↗
Apr 16, 26
▲ Buy · 🎯$47
Price at call : $24.71 — upside +90%
Today : $25.59 — upside +84%
🎯 on DOCS : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Apr 16, 27
matures : Apr 16, 27
▲ Overweight · 🎯$30
Price at call : $22.66 — upside +32%
Today : $25.59 — upside +17%
🎯 on DOCS : no call matured yet · 📊 on Health : 32.6% · -10.5% (43 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Goldman Sachs ↗
Apr 9, 26
■ Neutral neutral · not a buy · 🎯$28
Price at call : $21.05 — gap to target +33%
Today : $25.59 — gap to target +9%
🎯 on DOCS : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Apr 9, 27
matures : Apr 9, 27
Evercore ISI Group ↗
Apr 8, 26
■ In-Line neutral · not a buy · 🎯$25
Price at call : $21.86 — gap to target +14%
Today : $25.59 — gap to target -2%
🎯 on DOCS : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
Freedom Capital Markets
Mar 18, 26
▲ Buy · 🎯$31
Price at call : $24.8 — upside +25%
Today : $25.59 — upside +21%
🎯 on DOCS : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Mar 18, 27
matures : Mar 18, 27
RBC Capital ↗
Mar 9, 26
▲ Outperform · 🎯$44
Price at call : $24.78 — upside +78%
Today : $25.59 — upside +72%
🎯 on DOCS : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Mar 9, 27
matures : Mar 9, 27
■ Neutral neutral · not a buy · 🎯$33
Price at call : $23.76 — gap to target +39%
Today : $25.59 — gap to target +29%
🎯 on DOCS : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Piper Sandler ↗
Feb 20, 26
▲ Overweight · 🎯$42
Price at call : $25.55 — upside +64%
Today : $25.59 — upside +64%
🎯 on DOCS : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
▲ Overweight · 🎯$38
Price at call : $25.96 — upside +46%
Today : $25.59 — upside +48%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
■ Neutral neutral · not a buy · 🎯$34
Price at call : $27.24 — gap to target +25%
Today : $25.59 — gap to target +33%
🎯 on DOCS : no call matured yet · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
Canaccord Genuity ↗
Feb 9, 26
▲ Buy · 🎯$34
Price at call : $27.24 — upside +25%
Today : $25.59 — upside +33%
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
Goldman Sachs ↗
Feb 9, 26
■ Neutral neutral · not a buy · 🎯$34
Price at call : $27.24 — gap to target +25%
Today : $25.59 — gap to target +33%
🎯 on DOCS : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
Wells Fargo ↗
Feb 6, 26
▲ Overweight · 🎯$45
Price at call : $27.5 — upside +64%
Today : $25.59 — upside +76%
🎯 on DOCS : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
■ Neutral neutral · not a buy · 🎯$40
Price at call : $27.5 — gap to target +45%
Today : $25.59 — gap to target +56%
🎯 on DOCS : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Morgan Stanley ↗
Feb 6, 26
▲ Overweight · 🎯$49
Price at call : $27.73 — upside +77%
Today : $25.59 — upside +91%
🎯 on DOCS : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Piper Sandler ↗
Feb 6, 26
▲ Overweight · 🎯$40
Price at call : $27.73 — upside +44%
Today : $25.59 — upside +56%
🎯 on DOCS : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Truist Securities ↗
Feb 6, 26
▲ Buy · 🎯$37
Price at call : $27.73 — upside +33%
Today : $25.59 — upside +45%
🎯 on DOCS : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$55
Price at call : $27.73 — upside +98%
Today : $25.59 — upside +115%
🎯 on DOCS : no call matured yet · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$50
Price at call : $27.73 — upside +80%
Today : $25.59 — upside +95%
🎯 on DOCS : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Wells Fargo ↗
Jan 20, 26
▲ Overweight · 🎯$55
Price at call : $41.1 — upside +34%
Today : $25.59 — upside +115%
🎯 on DOCS : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
▲ Overweight · 🎯$60
Price at call : $43.74 — upside +37%
Today : $25.59 — upside +134%
🎯 on DOCS : no call matured yet · 📊 on Health : 32.6% · -10.5% (43 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
Morgan Stanley ↗
Dec 15, 25
▲ Overweight · 🎯$65
Price at call : $44.65 — upside +46%
Today : $25.59 — upside +154%
🎯 on DOCS : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
▲ Overweight · 🎯$63
Price at call : $45.04 — upside +40%
Today : $25.59 — upside +146%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
Raymond James ↗
Nov 21, 25
▲ Strong Buy · 🎯$65
Price at call : $49.95 — upside +30%
Today : $25.59 — upside +154%
🎯 on DOCS : no call matured yet · 📊 on Health : 42.1% · -4.4% (114 calls)
in progress (365j)
matures : Nov 21, 26
matures : Nov 21, 26
BMO Capital ↗
Nov 13, 25
■ Market Perform neutral · not a buy · 🎯$55
Price at call : $49.72 — gap to target +11%
Today : $25.59 — gap to target +115%
🎯 on DOCS : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
Leerink Partners ↗
Feb 7, 25
▲ Outperform · 🎯$90
Price at call : $83.14 — upside +8%
Today : $25.59 — upside +252%
Expected +8% · Actual -67% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 0% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
-66.9%
stock -67% · XLV +7%
matured Feb 7, 26
Canaccord Genuity ↗
Aug 20, 24
▲ Buy · 🎯$40
Price at call : $36.23 — upside +10%
Today : $25.59 — upside +56%
Expected +10% · Actual +78% · Reason (≥ +15%) : ✓ Yes
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+77.6%
stock +78% · XLV -11%
matured Aug 20, 25
Leerink Partners ↗
Feb 26, 24
■ Market Perform neutral · not a buy · 🎯$32
Price at call : $27.99 — gap to target +14%
Today : $25.59 — gap to target +25%
🎯 on DOCS : 0% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Feb 25, 25
matures : Feb 25, 25
Canaccord Genuity ↗
Sep 5, 23
▲ Buy · 🎯$33
Price at call : $24.06 — upside +37%
Today : $25.59 — upside +29%
Expected +37% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+48.4%
stock +48% · XLV +18%
matured Sep 4, 24
Canaccord Genuity ↗
Jun 7, 23
▲ Buy · 🎯$40
Price at call : $31.93 — upside +25%
Today : $25.59 — upside +56%
Expected +25% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-7.7%
stock -8% · XLV +13%
matured Jun 6, 24
Canaccord Genuity ↗
May 17, 23
▲ Buy · 🎯$40
Price at call : $33.31 — upside +20%
Today : $25.59 — upside +56%
Expected +20% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-15.8%
stock -16% · XLV +12%
matured May 16, 24
Canaccord Genuity ↗
Feb 10, 23
▲ Buy · 🎯$41
Price at call : $31.72 — upside +29%
Today : $25.59 — upside +60%
Expected +29% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-4.0%
stock -4% · XLV +9%
matured Feb 10, 24
Canaccord Genuity ↗
Aug 5, 22
▲ Buy · 🎯$42
Price at call : $40.61 — upside +3%
Today : $25.59 — upside +64%
Expected +3% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-15.2%
stock -15% · XLV +2%
matured Aug 5, 23
Canaccord Genuity ↗
Jul 19, 21
▲ Buy · 🎯$64
Price at call : $56.7 — upside +13%
Today : $25.59 — upside +150%
Expected +13% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-24.6%
stock -25% · XLV +2%
matured Jul 19, 22
Frequently asked questions
Should I buy Doximity stock?
This isn't buy advice. For Doximity, the analyst consensus is "Hold", with an average price target of $26.50 (+4% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 50% of the time (2 calls tracked on Doximity). We show the numbers — you decide.
Is it too late to buy Doximity? How high can it go?
The most bullish analyst target on Doximity is $47.00 (+84% above today's price); the average is $26.50. That's the upside they see. Check how reliable those analysts have actually been on Doximity on our site before trusting it.
Is Doximity still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 15 analysts have a real record on Doximity, the best hitting 50% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Will Doximity stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will DOCS stock recover (go back up)?
Should you invest in Doximity? The case for and against
The arguments for and against, one by one, from the numbers: why invest in DOCS (and why hesitate).
What has Doximity's past performance been?
Historical returns and a "how much if I had invested" calculator: DOCS performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX